In silico study demonstrates efficient umami peptide discovery in Douchi, indicating enhanced predictive modeling for taste-active compounds.
In this study, a partial least squares discriminant analysis (PLS-DA) discriminant model for umami peptides was constructed based on molecular dynamics simulation data, achieving a R 2 value of 0.949 and a Q 2 value of 0.558. Using this novel model and bioinformatics screening methods, five new umami peptides (EALEATAQ, SPPTEE, SEEG, KEE, and FEE, with umami taste thresholds of 0.139, 0.085, 0.096, 0.060, and 0.079 mg/mL, respectively) were identified in Douchi. Molecular docking revealed that the residues ASN150 of T1R1, as well as SER170, GLU301 and GLN389 of T1R3, might be key amino acid residues for the binding of umami peptides to T1R1/T1R3. Molecular dynamics simulations revealed significant differences in the root-mean-square fluctuation (RMSF) values between the two complex systems of umami peptides-T1R1/T1R3 and non-umami peptides-T1R1/T1R3. The newly constructed umami peptide discriminant model can improve the accuracy of umami peptide screening and enhance the efficiency of discovering new umami peptides. • A new umami peptide discriminant model was developed. • Five novel umami peptides sequences were identified (EALEATAQ, SPPTEE, SEEG, KEE, and FEE). • The ASN150 of T1R1 was the key amino acid reside binding to umami peptide. • The SER170, GLU301 and GLN389 of T1R3 were the key amino acid resides binding to umami peptide. • The difference in structural of T1R1/T1R3 bind with umami or non-umami peptides were identified.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: